Valiant Laboratories Limited is an India-based pharmaceutical ingredient manufacturing company. The Company is focused on manufacturing a Paracetamol active pharmaceutical ingredient (API)/bulk drug. It has several applications in the treatment of conditions such as headache, muscle ache, arthritis, backache, toothache, cold and fever. It is also used in the management of severe pain such as post-surgical and cancer pain. It operates a single-location manufacturing facility on the Tarapur industrial estate.

Employees

Sector

Specialty Chemicals

More about the company

Quotes

Date	Price	Change	Volume
18/26/18	₹123.26	+0.42%	1,55,553
17/26/17	₹122.75	+5.00%	67,876
16/26/16	₹116.91	-4.66%	1,11,457
15/26/15	₹122.63	-4.13%	1,04,961
11/26/11	₹127.91	+2.49%	2,34,978

End-of-day quote NSE India S.E.

More quotes

End-of-day quote NSE India S.E. 18/09/2026			5-day change	1st Jan Change
123.26 ^INR	+0.42%		-3.64%	+76.09%

10/08	Valiant Laboratories Limited Reports Earnings Results for the First Quarter Ended June 30, 2026	CI
10/08	Valiant Laboratories Limited Approves the Opening of New Corporate Office	CI

Market Cap	669.46Cr 6.98Cr 6.08Cr 5.74Cr 5.22Cr 9.77Cr 9.81Cr 69Cr 27Cr 340.36Cr 26Cr 26Cr 1.1TCr	P/E 2025	-150x	P/E 2026	-79.4x
Enterprise Value	682.52Cr 7.11Cr 6.2Cr 5.86Cr 5.32Cr 9.96Cr 10Cr 70Cr 27Cr 347Cr 27Cr 26Cr 1.12TCr	EV / Sales 2025	2.83x	EV / Sales 2026	1.24x
Free-Float	23.22%	Yield 2025 *	-	Yield 2026	-

Markets		Quality
NSE India S.E.	VALIANTLAB	End-of-day quote
Bombay S.E.	VALIANTLAB	Delayed

10/08	Valiant Laboratories Limited Reports Earnings Results for the First Quarter Ended June 30, 2026	CI
10/08	Valiant Laboratories Limited Approves the Opening of New Corporate Office	CI
20/05	Valiant Organics Limited agreed to acquire 34.26% stake in Valiant Laboratories Limited from Dhanvallabh Ventures LLP.	CI
14/05	Valiant Laboratories Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2026	CI
23/04	Valiant Laboratories Limited Announces Resignation of Bhanudas D. Patil as Q.C Manager, Senior Management Personnel, Effective April 22, 2026	CI
11/02	Valiant Laboratories Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2025	CI
15/01	Valiant Laboratories Ltd receives notice for total tax demand of approx. 125.3 million rupees	RE
12/11	Valiant Laboratories Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2025	CI
07/11	Valiant Laboratories Arm Begins Commercial Operations at New Unit in Gujarat, India; Shares Up 4%	MT
25/25/25	Valiant Laboratories Limited Approves Change in Designation of Paresh Shah from Executive Director to Whole-Time Director, Effective September 25, 2025	CI
09/25/09	Valiant Laboratories Limited Reports Earnings Results for the First Quarter Ended June 30, 2025	CI
16/25/16	Valiant Laboratories Gets Board Nod for INR815 Million Rights Issue; Shares Up 4%	MT
15/25/15	Valiant Laboratories says rights issue price set at 75 rupees per share, entitlement ratio 1:4	RE

Valiant Laboratories Limited Share Price

Stocks

VALIANTLAB

INE0JWS01017

Specialty Chemicals

Valuation: Valiant Laboratories Limited

Chart: Valiant Laboratories Limited

Latest news: Valiant Laboratories Limited

Quotes and Performance

Price Extremes

Managers and Directors: Valiant Laboratories Limited

Other Specialty Chemicals

Financials

Company Profile

Quotes

1 day	+0.42%
1 week	-3.64%
Current month	+27.94%
1 month	+34.04%
3 months	+81.53%
6 months	+122.93%
Current year	+76.09%

1 week	111.25	129.5
1 month	90.94	129.9
Current year	49.51	129.9
1 year	49.51	129.9
3 years	49.51	214.95
5 years	49.51	214.95
10 years	49.51	214.95

Manager	Title	Age	Since
Santosh Vora CEO	Chief Executive Officer	32	21/08/2021
Paresh Shah DFI	Director of Finance/CFO	66	16/08/2021
Akshay Dnyaneshwar Gangurde CMP	Compliance Officer	-	09/07/2025

Director	Title	Age	Since
Santosh Vora BRD	Director/Board Member	32	21/08/2021
Sonal Amit Vira BRD	Director/Board Member	43	16/02/2022
Paresh Shah BRD	Director/Board Member	66	16/08/2021

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
VALIANT LABORATORIES LIMITED	+0.42%	-3.64%	+41.24%	-	6.98Cr
ECOLAB INC.	-0.82%	-2.43%	+1.50%	+52.83%	7.55TCr
GIVAUDAN SA	-0.64%	+2.69%	-1.99%	+14.77%	3.64TCr
SIKA AG	-1.22%	-1.38%	+1.36%	-23.69%	3.56TCr
FUJIFILM HOLDINGS CORPORATION	-0.51%	+3.07%	-6.47%	+9.43%	2.53TCr
EMS-CHEMIE HOLDING AG	-1.36%	+0.38%	+38.24%	+25.04%	2.27TCr
SOCIEDAD QUÍMICA Y MINERA DE CHILE S.A.	-5.68%	-3.09%	+55.79%	+12.92%	1.93TCr
DUPONT DE NEMOURS, INC.	+0.43%	+1.59%	-44.94%	-42.25%	1.74TCr
NITTO DENKO CORPORATION	-0.68%	+5.52%	-0.97%	+66.44%	1.43TCr
SYMRISE AG	-1.20%	+2.09%	+17.56%	-0.04%	1.4TCr
Average	-1.13%	+0.69%	+10.13%	+12.83%	2.61TCr
Weighted average by Cap.	-1.16%	+0.26%	+5.08%	+19.02%

	2025	2026
Net sales	133.38Cr 1.39Cr 1.21Cr 1.14Cr 1.04Cr 1.95Cr 1.96Cr 14Cr 5.29Cr 68Cr 5.22Cr 5.11Cr 218.2Cr	237.47Cr 2.47Cr 2.16Cr 2.04Cr 1.85Cr 3.47Cr 3.48Cr 24Cr 9.42Cr 120.73Cr 9.3Cr 9.09Cr 388.47Cr
Net income	-2.2Cr -2L -2L -2L -2L -3L -3L -22.63L -9L -1.12Cr -9L -8L -3.6Cr	-3.27Cr -3L -3L -3L -3L -5L -5L -33.59L -12.96L -1.66Cr -12.79L -12.51L -5.35Cr
Net Debt	45Cr 47.2L 41.16L 38.86L 35.29L 66.12L 66.4L 4.66Cr 1.8Cr 23Cr 1.77Cr 1.73Cr 74Cr	13Cr 13.61L 11.87L 11.21L 10.18L 19.07L 19.15L 1.34Cr 51.81L 6.64Cr 51.14L 50L 21Cr